
10/01/2025
We must push back against this unnecessary overreach by the FDA so that patients like you are not collateral damage in a policy change that in effect clears the field to create a monopoly for one drugmaker.
Here's what you should know:
The FDA recently announced plans to restrict natural desiccated thyroid (NDT/“natural thyroid”)—a treatment many patients rely on.
The FDA now classifies natural thyroid as a “biologic”, which means compounding pharmacies may soon be prohibited from making it.
Patients could be forced to switch to synthetic-only options, even if those haven’t worked well in the past.
This could impact up to 1.9 million patients nationwide who depend on NDT.
The FDA is giving only 12 months for patients to transition. We must act now before the enforcement window closes.
We need patients and health care professionals to take action! Your voice needs to be heard, you can contact lawmakers directly through the link in the comments.
Thank you for your help in preserving patient access to DTE. Every letter sent, every story, and every voice matters.